BOISE, Idaho — Albertsons has reached a settlement to resolve any federal, state, or tribal-based legal claims involving opioids.
In a news release, Albertsons Companies, Inc. clarified that the settlement, which totals $774 million, "is not an admission of wrongdoing or liability."
Meanwhile, Purdue Pharma, the creator of the prescription opioid OxyContin, is working to reach a settlement to resolve the thousands of lawsuits that name the company as a defendant regarding its role in the opioid crisis. The Associated Press reports that U.S. District Judge Madeline Cox Arleo will soon order the company to forfeit $225 to the Department of Justice before it can finalize a settlement.
"[Albertsons] is continuing its ongoing commitment to patient safety, responsible pharmacy operations, robust training and tools for pharmacy teams, and being a constructive partner in addressing the opioid crisis," concludes the company statement regarding the settlement.
Albertsons currently operates 2,244 grocery stores and 1,713 pharmacies across 35 states.
